The National Alzheimer’s Disease Index is a new precision public-health tool for analytics and decision modeling in support of communities with high rates of Alzheimer’s and related dementias and health disparities.
If you are interested in learning more about the development of this tool and accessing data for your research and public health promotion efforts, please fill out the below form.
The disproportionate impact of Alzheimer’s disease on people of color and women is creating ripple effects across communities and our nation, limiting economic opportunity and straining health systems. In response, UsAgainstAlzheimer’s has developed the National Alzheimer’s Disease Index, a new tool, to help public health practitioners, researchers, drug developers, communities and policymakers identify, visualize and address Alzheimer’s health disparities. It will help UsAgainstAlzheimer’s and its partners increase awareness, improve clinical practice, increase research diversity and ultimately improve health outcomes among underserved populations living with Alzheimer’s disease.
The National Alzheimer’s Disease Index is a public health tool that aggregates Medicare data and enables the field to visualize and analyze Alzheimer’s health statistics by geography and by demographics. Guided by an interdisciplinary working group of experts, the tool will help catalyze the health system change needed to advance health equity in Alzheimer’s research and health services.